((Automated translation by Reuters, please see disclaimer https://bit.ly/rtrsauto))
Delaware’s highest court said Tuesday it will hear an appeal by GSK GSK.L and other drugmakers seeking to end more than 70,000 lawsuits claiming that Zantac, a discontinued heartburn drug, caused cancer.
GSK, Pfizer PFE.N , Sanofi SASY.PA and Boehringer Ingelheim are asking the court to overturn a trial judge’s order allowing the plaintiffs to present expert testimony on the alleged cancer link. The companies have denied the allegations.